Closer Ties to Industry Promised in Revised CIRM Strategic Plan
The California stem cell agency has quietly unveiled its latest plan on how it intends to spend nearly $3 billion over the next nine years, including a major shift into backing research intended to drive therapies into the marketplace.
The proposal, a revision of the 2006 strategic plan, calls for much closer ties with the biotech industry, "dramatic in…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.